This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB04318/identifier/pdb/
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04318/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04318/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB04318/identifier/drugbank/

Statements

Subject Item
n2:DB04318
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n8:DB04318 n11:DB04318
dcterms:title
1-Benzyloxycarbonylamino-2-Phenyl-Ethyl)-{2-[1-Carbamoyl-2-(1h-Indol-3-Yl)-Ethylcarbamoyl]-5-Phenyl-Pentyl}-Phosphinic Acid
adms:identifier
n6:DB04318 n9:46504852 n10:RXP n12:46936947
n3:IUPAC-Name
n4:271B4F05-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4F0B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4F0A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4F07-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4F08-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4F09-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4F03-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4F01-363D-11E5-9242-09173F13E4C5 n4:271B4F04-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4F02-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4F11-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4F12-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4F0C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4F0D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4F0F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4F0E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4F10-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4F17-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4F19-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4F1A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4F16-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4F15-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4F18-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4F06-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4F13-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4F14-363D-11E5-9242-09173F13E4C5